Kyntra Bio, Inc. Common Stock (KYNB)
Kyntra Bio, Inc. Common Stock (KYNB) has reported earnings 21 times since Aug 09, 2021. The stock moves an average of ±8.11% the day after reporting, closing higher 38.1% of the time. Its largest post-earnings gain was +25.6% (May 09, 2022) and its largest decline was -23.6% (Mar 17, 2025). The next earnings report is predicted for 2026-11-11 (estimated).
Earnings reactions
How KYNB moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±8.11%
Positive %
38.1%
Negative %
61.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☽ POST | -2.29% | open_in_new |
| May 11, 2026 | ☽ POST | +0% | open_in_new |
| Mar 16, 2026 | ☽ POST | +0% | open_in_new |
| Nov 10, 2025 | ☽ POST | -9.84% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±8.11%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260831 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 8-K | 20260616 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
Frequently asked about KYNB earnings
When does Kyntra Bio, Inc. Common Stock report earnings next? expand_more
Kyntra Bio, Inc. Common Stock (KYNB)'s next earnings date is estimated for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KYNB stock move after earnings? expand_more
Over 21 reports, KYNB has moved an average of ±8.11% the session after earnings, closing higher 38.1% of the time.
What was KYNB's biggest post-earnings move? expand_more
KYNB's largest post-earnings gain on record was +25.6% on May 09, 2022, and its largest decline was -23.6% on Mar 17, 2025.
Where can I find Kyntra Bio, Inc. Common Stock's SEC filings? expand_more
All of Kyntra Bio, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right